The potential of TB treatment 8 weeks

Published Date: 08 Mar 2023

While some say this strategy's failure rate is "too high," it's one step closer to the "white grail" of a shorter 24-week formula.

Read Full News

Latest News

COVID may increase risk of dangerous blood clots after panniculectomy

Among patients undergoing panniculectomy to remove excess abdominal skin, those with previous COVID may be at higher risk of serious blood clot-related complications called venous thromboembolism (VTE), reports a study in ...

Video messaging alone insufficient strategy to boost COVID vaccination rates

A new study by Assistant Professor Rachael Piltch-Loeb, Affiliated Investigator Angela Parcesepe, Distinguished Professor Denis Nash, and colleagues from the CUNY Institute for Implementation Science in Population Health ...

Clinical trial shows efficacy of bacteriophage therapy for Staphylococcus aureus bacteremia

During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, presented findings from the Phase IIa diSArm study. Dr. Miller ...

'Forever chemical' PFHpA identified as risk factor for severe liver disease in adolescents

Scientists at the Keck School of Medicine of USC, working within the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and Prevention (ShARP) Center, have uncovered compelling evidence ...

Some acute and chronic viral infections may increase the risk of cardiovascular disease

In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according ...

Inhibiting a problematic protein helps immunotherapies, CAR T-cell therapy to fight off melanoma more effectively

Melanoma, the deadliest form of skin cancer, can't always be removed with a scalpel.

Todays Updates

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Todays Updates

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Latest News

Among patients undergoing panniculectomy to remove excess abdominal skin, those with previous COVID may be at higher risk of serious blood clot-related complications called venous thromboembolism (VTE), reports a study in ...

A new study by Assistant Professor Rachael Piltch-Loeb, Affiliated Investigator Angela Parcesepe, Distinguished Professor Denis Nash, and colleagues from the CUNY Institute for Implementation Science in Population Health ...

During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, presented findings from the Phase IIa diSArm study. Dr. Miller ...

Scientists at the Keck School of Medicine of USC, working within the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and Prevention (ShARP) Center, have uncovered compelling evidence ...

In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according ...

Melanoma, the deadliest form of skin cancer, can't always be removed with a scalpel.

News All Time

Exploring role of time-restricted eating in controlling metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where excess fat builds up in the liver due to metabolic risk factors. The cornerstone for treating MASLD is managing the underlying metabolic ...

New clinical tool can measure severity of debilitating skin disorders

A new clinical tool may improve how physicians assess the severity of a painful and often debilitating skin disorder, according to a study recently published in JAMA Dermatology.

Combined HIV vaccines can act in concert to achieve diverse antibody priming

Researchers at La Jolla Institute for Immunology, Scripps Research, and the Ragon Institute of MGH, MIT, and Harvard report coordinated studies showing that several HIV germline-targeting immunogens can be delivered together ...

How HIV disrupts sleep across Africa

HIV significantly affects sleep, with many affected people living in a state akin to chronic jet lag. A new study with Wits researchers published in The Lancet HIV describes how people living with HIV (PLWHIV) experience ...

Immune cells linked to allergies may double as defenders against Candida infections

A new study has uncovered how a surprising player in the immune system, eosinophils, best known for their role in allergies and asthma, also helps protect the body against Candida albicans, one of the most common and dangerous ...

Mitochondrial epilepsy could originate in a specific group of brain neurons

A team led by the UAB Institut de Neurociències (INc-UAB) has for the first time identified the mechanism behind a potentially fatal type of epilepsy, a symptom of mitochondrial diseases. The discovery, based on mouse models, ...

New study reveals hidden burden of multiple sclerosis on quality of life

A major UK-wide study led by researchers based in Liverpool has revealed the profound impact of multiple sclerosis (MS) on health-related quality of life, with findings that could reshape how services and resources are allocated ...

Henna's hidden healing: Treating fibrosis with a chemical derived from Lawsonia inermis

Lawsonia inermis is best known for making henna, a versatile dye that is used to change the color of skin and clothes. Now, researchers from Osaka Metropolitan University have found another use for the pigments extracted ...

Despite the confusion, vaccines should be in reach this season, says CDC

For people whose autumn agenda includes getting vaccinated against respiratory diseases—COVID, flu, and, for some, RSV—this year may be surprisingly routine.

Taking down malaria's bodyguards: Scientists target parasite's secret defense system

Malaria remains one of the world's most devastating infectious diseases, claiming more than half a million lives each year. In Africa, the illness is mostly caused by a parasite carried by mosquitoes—Plasmodium falciparum.

New 2025 data shows COVID-19 vaccines continue to provide effective, durable protection

Updated COVID-19 vaccines are still providing effective protection against infection, emergency department visits, hospitalization and death, according to new research published in JAMA Internal Medicine.

Elderly migrants in Swedish care homes faced higher COVID-19 mortality risk

Migrants from low-income countries living in care settings in Sweden were more likely to die from COVID-19 than people born in the country during the first year of the pandemic, according to a new study by researchers from ...

Integrated surveillance tops future One Health research priorities

Integrated surveillance systems that unite human, livestock, agricultural, and ecosystem experts to support early detection, community engagement, and rapid response top the five future research priorities of One Health.

NZ may be on the cusp of another measles outbreak—what happened in 2019 should be a warning

The recent confirmation of new measles cases unconnected to international travel suggests the highly contagious disease has likely started spreading through communities, according to Health New Zealand.

HIV prevention jab approved for use in England and Wales. Here's how it works

The first ever injectable drug that can prevent HIV has been approved for use in England and Wales.

Malaria risk in the Amazon found to be higher in regions with intermediate forest degradation

Amid the preparatory discussions for COP30, which also involve health-related topics, a study contributes to our understanding of the relationship between deforestation and the spread of malaria in the Legal Amazon. This ...

Recommended News For You

New guidelines for radiation therapy for HPV-associated head and neck cancer

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

Including Bereavement in the Care Continuum.

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

Recommended Articles For You

Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics 

A Visual Journey Through Penile Cancer: Examining the Impact of Photos 

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment 

Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

4.

What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'

5.

Adult overdose deaths on the rise

1.

Unlocking The Power Of Cangrelor To Treat Heart Disease

2.

Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential

3.

Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management

4.

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer

5.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

3.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot